North Carolina Glaxosmithkline Foundation
- Assets
- $63.4m
- Revenue
- $4.7m
- Investments
- $62.8m
- Employees
- 0
- Location
- Durham, NC
- Founding
- 11/1986
- Data as of
- 12/2022
- EIN
- 58-1698610
Organization Overview
North Carolina Glaxosmithkline Foundation is located in Durham, NC. The organization was established in 1986. According to its NTEE Classification (T20) the organization is classified as: Private Grantmaking Foundations, under the broad grouping of Philanthropy, Voluntarism & Grantmaking Foundations and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. North Carolina Glaxosmithkline Foundation is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2022, North Carolina Glaxosmithkline Foundation generated $4.7m in total revenue. This represents relatively stable growth, over the past 8 years the organization has increased revenue by an average of 5.1% each year. All expenses for the organization totaled $3.9m during the year ending 12/2022. You can explore the organizations financials more deeply in the financial statements section below.
Since 2015, North Carolina Glaxosmithkline Foundation has awarded 194 individual grants totaling $24,319,775. If you would like to learn more about the grant giving history of this organization, scroll down to the grant profile section of this page.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Robert A Ingram Chairman | 0.46 | $3,000 | |
S Mark Werner Director | 0.46 | $4,000 | |
Ann B Goodnight Director | 0.46 | $4,000 | |
Margaret B Dardess Director | 0.46 | $4,000 | |
Shirley T Frye Director | 0.46 | $4,000 | |
Thomas R Haber Director | 0.46 | $4,000 |
Outside Vendors & Contractors
| Vendor Name (Service) | Service Year | Compensation |
|---|---|---|
Glaxosmithkline Inc | 12/30/22 | $700,104 |
Miller Portfolio Advisors | 12/30/22 | $120,184 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Contributions, Gifts, Grants & Similar | $129,326 |
| Interest on Savings | $0 |
| Dividends & Interest | $3,201,285 |
| Net Rental Income | $0 |
| Net Gain on Sale of Assets | $1,340,276 |
| Capital Gain Net Income | $1,340,276 |
| Net ST Capital Gain | $0 |
| Income Modifications | $0 |
| Profit on Inventory Sales | $0 |
| Other Income | $0 |
| Total Revenue | $4,670,887 |
| Statement of Expenses | |
|---|---|
| Compensation of officers, directors, trustees, etc | $42,079 |
| Other employee salaries and wages | $741,627 |
| Pension plans, employee benefits | $0 |
| Interest | $0 |
| Taxes | $0 |
| Depreciation | $0 |
| Occupancy | $46,010 |
| Travel, conferences, and meetings | $3,898 |
| Printing and publications | $0 |
| Other expenses | $214,471 |
| Total operating and administrative expenses | $1,195,289 |
| Contributions, gifts, grants paid | $2,751,943 |
| Total expenses and disbursements | $3,947,232 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $0 |
| Savings and temporary cash investments | $597,047 |
| Net Accounts receivable | $0 |
| Net Pledges Receivable | $0 |
| Grants receivable | $0 |
| Receivables from Officers, Directors, or Controlling Persons | $0 |
| Net other notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $0 |
| Net Investments - land, buildings, equipment | $0 |
| Investments—mortgage loans | $0 |
| Investments—other | $62,769,708 |
| Net Land, buildings, and equipment | $0 |
| Other assets | $0 |
| Total assets | $63,366,755 |
| Accounts payable and accrued expenses | $27,956 |
| Grants payable | $6,212,674 |
| Deferred revenue | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Mortgages and other notes payable | $0 |
| Other liabilities | $80,864 |
| Total liabilities | $6,321,494 |
Grants Awarded
Over the last fiscal year, North Carolina Glaxosmithkline Foundation has awarded $2,751,943 in support to 5 organizations.
| Grant Recipient | Amount |
|---|---|
EAST CAROLINA UNIVERSITY FOUNDATION INC PURPOSE: TO SUPPORT "GROWING A DIVERSE PUBLIC HEALTH WORKFORCE FOR RURAL NORTH CAROLINA THROUGH GRADUATE SCHOOL PATHWAYS." | $1,315,000 |
MCREL PURPOSE: FUNDING TO CONTINUE PROVIDING ASSISTANCE IN THE IMPLEMENTATION AND EVALUATION OF THE RIBBON OF HOPE PROGRAM, FROM APRIL 2022 TO MARCH 2023. | $41,943 |
NORTH CAROLINA PUBLIC HEALTH ASSOCIATION PURPOSE: FUNDING FOR CHILD HEALTH AWARDS | $40,000 |
THE CENTER FOR INQUIRY BASED LEARNING INC PURPOSE: TO PROVIDE FUNDING TO ESTABLISH THE INCREASING SCIENCE, TEACHING, AND LEARNING (INSTAL) PROJECT BY PROVIDING SCIENCE MATERIAL KITS TO TWO MARTIN COUNTY MIDDLE SCHOOLS. | $25,000 |
UNC CHAPEL HILL PURPOSE: TO SUPPORT THE EQUITY FELLOWS PROGRAM, DESIGNED TO ADDRESS ISSUES OF DISADVANTAGED STUDENTS WHO DON'T GRADUATE ON TIME WITH AN UNDERGRADUATE DEGREE AND THE DROP-OUT ISSUE OF THESE STUDENTS. | $1,330,000 |